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Abstract
To investigate the major causes and predictive factors of death in a middle-aged and elderly Chinese population. A total 
of 6591 residents aged ≥ 45 years from Shanghai Changfeng community were followed up for an average of 5.4 years. The 
causes of death were coded according to the 10th Revision of International Classification of Diseases. The mortality rate 
was calculated by person-years of follow up and age-standardized according to the 2010 Chinese census data. Multivariable-
adjusted Cox proportional hazards model was performed to investigate the predictors of all-cause and cause-specific mortality. 
During the total follow-up of 35,739 person-years, 370 deaths were documented (157 from malignant neoplasms, 70 from 
heart diseases, 68 from cerebrovascular diseases, 75 from other causes). The age-standardized all-cause mortality rate was 
798.2 per 100,000 person-years (927.9 among men and 716.7 among women). Results from multivariable analyses showed 
that aging, diabetes, and osteoporosis at baseline were independent predictors of all-cause mortality, with hazard ratios (HR) 
of 1.11 (95% CI 1.10–1.13), 1.91 (1.51–2.42), and 1.71 (1.24–2.35), respectively. The population attributable risk percent 
of diabetes and osteoporosis was 19.7% and 11.7%, respectively. Cigarette smoking was associated with a higher risk of all-
cause mortality in men (HR and 95%CI 1.44, 1.01–2.06). In women, diabetes and osteoporosis were related to a higher risk 
of cardiovascular mortality (3.27, 1.82–5.88 and 1.89, 1.04–3.46, respectively). While in men, osteoporosis was related to a 
higher risk of malignant neoplasms mortality (2.39, 1.07–5.33). Malignant neoplasms, heart diseases, and cerebrovascular 
diseases are the leading causes of death. Aging, smoking, underweight, diabetes, and osteoporosis are independent predictors 
of premature death among middle-aged and elderly Chinese community population. Moreover, there may have been some 
differences in the causes and predictors of premature death between men and women.
Keywords Causes of death · Risk factors · Middle-aged and elderly Chinese population
Li Wu and Huandong Lin have contributed equally to this work.
 * Xin Gao 
 happy20061208@126.com; zhongshan_endo@126.com
1 Department of Endocrinology and Metabolism, Zhongshan 
Hospital, Fudan University, Shanghai 200032, China
2 Fudan Institute for Metabolic Diseases, Shanghai 200032, 
China
3 Department of Geriatrics, Zhongshan Hospital, Fudan 
University, Shanghai 200032, China
4 Department of Gastroenterology, Zhongshan Hospital, Fudan 
University, Shanghai 200032, China
5 Department of Clinical Nutrition, Zhongshan Hospital, 
Fudan University, Shanghai 200032, China
6 Department of Laboratory Medicine, Zhongshan Hospital, 
Fudan University, Shanghai 200032, China
7 Network Information Center, Zhongshan Hospital, Fudan 
University, Shanghai 200032, China
8 Department of Biostatistics, School of Public Health, Fudan 
University, Shanghai 200032, China
9 Department of Neuroscience, Erasmus Medical Center, 
Rotterdam, The Netherlands
10 Department of Epidemiology, Harvard T.H. Chan School 
of Public Health, Boston, MA, USA
11 State Key Laboratory of Genetic Engineering, Human 
Phenome Institute and School of Life Sciences, Fudan 
University, Shanghai, China
 L. Wu et al.
1 3
Introduction
Globally, rapid economic development and improvement in 
living conditions, nutrition, and health care have resulted in 
declines in infant mortality and deaths from infectious dis-
eases and increases in life expectancy during the past three 
decades [1, 2]. In contrast, urbanized lifestyle (calorie-dense 
diet and sedentary environment) accompanied with the aging 
population have led to the rapid rise in prevalence of chronic 
non-communicable diseases (NCDs), such as cardiovascular 
diseases, cancers, chronic pulmonary diseases, and diabetes 
mellitus [3]. The Global Burden of Diseases Study 2016 (GBD 
2016) reported that mortality due to NCDs increased from 
57% of total mortality in 1990 to 72.3% in 2016 [1]. In China, 
with remarkable economic and social development, the life 
expectancy at birth increased by 8.5 years from 1990 to 2013 
[4], and NCDs caused mortality has increased from 69.2 to 
86.6% of the total annual deaths during the same period [5].
Changes in mortality and its main causes are important 
indicators of national health. China has been undergoing tre-
mendous demographic and epidemiological transitions during 
the past three decades, but the leading health problems differ 
across different regions [5]. Local health policies are needed 
to be made to deal with the diverse challenges faced by local 
health-care systems. With the improvement of the death sur-
veillance system, investigation of death causes and risk factors 
have become possible [6].
However, most previous death investigations were con-
ducted among the whole population, the surveys focused on 
middle-aged and elderly population were limited. Gu et al. [7] 
ever estimated the major causes and preventable risk factors of 
mortality among Chinese adults aged 40 years or older from 
1991 to 2000. Since then, there were few studies estimating the 
causes and risk factors for mortality among Chinese middle-
aged and elderly population, and most of the existing ones 
were conducted in a specific population, such as the retired 
military veterans [8] or male steelworkers [9]. Shanghai is one 
of the most developed cities in China, the aging tendency of 
its population is more severe than most other Chinese cities. 
Valid information on mortality and its modifiable risk factors 
is crucial for health policy to set priority for the prevention of 
premature death. In this study, using data from the Shanghai 
Changfeng study [10, 11], we aimed to investigate the major 
causes and predictive factors of premature death in a Chinese 
community population aged 45 years and older.
Methods
Study population
The participants were from Shanghai Changfeng Study, 
a prospectively observational community-based cohort 
study, which is focused on chronic diseases among the 
middle-aged and elderly. Details of the study informa-
tion have been described elsewhere [10]. The Changfeng 
community is a middle-class community located in the 
north-west part of Shanghai. The inclusion criteria of 
participants were: (1) aged 45 years or older, (2) lived 
in Changfeng community for at least 5 years. Our study 
population can represent the general adult population 
aged 45 years or older in Shanghai. From June 2009 to 
December 2012, 6595 residents were enrolled. During the 
follow-up period, 4 participants missing the vital status 
record were excluded. Eventually, 6591 individuals were 
included in our final analyses. This study was approved by 
the ethical committee of Zhongshan Hospital affiliated to 
Fudan University and informed consent was obtained from 
all individual participants.
Baseline examination
Information on sociodemographic variables, including 
age, gender, cigarette smoking, and alcohol consumption, 
were collected through face-to-face interviews using struc-
tured questionnaires. The participants were instructed to 
maintain their usual lifestyle for at least 3 days before each 
examination. Cigarette smoker was defined as smoking at 
least one cigarette per day for one or more years. Regular 
alcohol consumption was defined as the average alcohol 
consumption of more than 10 g of absolute alcohol per day 
for 1 year or longer.
Height and weight were measured with the participants 
wearing light clothes without shoes. Body mass index 
(BMI) was calculated as weight in kilograms divided by 
the square of height in meters (kg/m2). Normal weight 
was defined as a BMI of 18.5 to < 24.0 kg/m2, under-
weight was defined as a BMI of < 18.5 kg/m2, overweight 
was defined as a BMI of 24.0 to < 28.0 kg/m2, and obe-
sity as a BMI of ≥ 28.0 kg/m2 according to Chinese cri-
teria [12]. Resting blood pressure was measured three 
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times in the same arm with an electronic blood pressure 
monitor (OMRON Model HEM-752 FUZZY, Omron Co., 
Dalian, China) after the participants had been sitting qui-
etly for at least 5 min, and the average of three measure-
ments was used for analysis. Hypertension was defined 
as a blood pressure ≥ 140/90  mmHg or self-reported 
current use of antihypertensive medications, and pre-
hypertension was defined as 120 ≤ systolic blood pres-
sure (SBP) ≤ 139 mmHg or 80 ≤ diastolic blood pressure 
(DBP) ≤ 89 mmHg [13].
Blood samples were collected after a fasting period of 
at least 10 h. Fasting plasma glucose (FPG), total cho-
lesterol (TC), triglyceride (TG), high-density lipoprotein 
cholesterol (HDL-C), and low-density lipoprotein cho-
lesterol (LDL-C) were measured using an automated bio-
analyzer (HITACHI 7600, Tokyo, Japan). Dyslipidemia 
was defined as TC ≥ 6.22 mmol/L, or TG ≥ 2.26 mmol/L, 
or LDL-C ≥ 4.14 mmol/L, or HDL-C < 1.04 mmol/L, or 
self-reported current use of antilipidemic agents [14]. 
The 2-h plasma glucose (2-h PG) was measured after 
a 75  g oral glucose tolerance test (OGTT). Diabetes 
mellitus (DM) was defined as FPG ≥ 7.0  mmol/L or 
2-hPG ≥ 11.1 mmol/L according to the WHO 1999 cri-
teria [15], or a previous diagnosis or self-reported cur-
rent treatment with hypoglycemic drugs. Pre-diabetes 
was defined as either impaired fasting glucose (FPG ≥ 6.1 
and < 7.0 mmol/L) or impaired glucose tolerance (2-h 
PG ≥ 7.8 and < 11.1 mmol/L). All blood samples were 
measured in the central laboratory of the Zhongshan Hos-
pital affiliated to Fudan University.
Bone mineral density (BMD) at the lumbar spine 
(L1–L4), femoral neck, and total hip were measured 
using dual-energy X-ray absorptiometry (GE Healthcare 
Lunar iDXA system) and conducted by a trained tech-
nician. Osteopenia was defined as a T score of − 1.0 to 
− 2.5 standard deviations (SD) and osteoporosis as a T 
score ≤ −2.5 SD according to the WHO criteria [16].
Follow‑up
We followed participants from the date of recruitment to 
the date of death or 31 December 2016, whichever came 
first. The mean follow-up time was 5.4 years. The vital 
status of participants was collected from the Shanghai 
Centers for Disease Control (SCDC), and the causes 
of death were coded according to the 10th Revision of 
International Classification of Diseases (ICD-10). The 
main endpoints during the follow-up were death due to 
malignant neoplasms (ICD-10 codes C00-C97), heart dis-
eases (ICD-10 codes I10-I52), cerebrovascular diseases 
(ICD-10 codes I60-I69), diabetes mellitus (ICD-10 codes 
E10-E14), respiratory diseases (ICD-10 codes J00-J99), 
digestive diseases (ICD-10 codes K00-K93), dementia 
(ICD-10 codes F00-F03) and accidents (ICD-10 codes 
V01-X59). All-cause mortality was defined as death due to 
any causes. Cardiovascular mortality was defined as death 
caused by coronary disease, stroke, and peripheral arterial 
disease. Malignant neoplasms mortality was defined as 
death due to malignant neoplasms.
Statistical analysis
Continuous variables were presented as mean ± standard 
deviation (SD) and categorical variables were presented as 
numbers (percentages). T test was used for comparison of con-
tinuous variables, whereas the Chi squared test was used for 
comparisons of categorical variables. The baseline character-
istics of participants were compared between men and women.
Participants contributed follow-up time was calculated from 
the date of recruitment to the date of death or 31 December 
2016, whichever came first. Age-standardized mortality was 
calculated by person-years of follow up and adjusted according 
to the 2010 census data in China [17]. Multivariable-adjusted 
Cox proportional hazards model was performed to estimate 
the hazard ratio (HR) and 95% confidence interval (95% CI) 
of predictive factors for all-cause and cause-specific mortality. 
Potential confounders included baseline age, gender, alcohol 
consumption, cigarette smoking, and existing diseases (yes/no) 
including obesity, diabetes, hypertension, dyslipidemia, and 
osteoporosis. To further analyze the associations of baseline 
age, BMI, glucose metabolism, blood pressure, bone mineral 
density with all-cause mortality, we introduced dummy vari-
ables in Cox analyses. Participants were divided into different 
groups according to age [45–54 (reference), 55–64, 65–74, 
and ≥ 75 years old], BMI [< 18.5, 18.5 to < 24.0 (reference), 
24.0 to < 28.0, and ≥ 28.0 kg/m2], glucose metabolism [Normal 
(reference), Pre-DM, New DM, and Prior DM], blood pressure 
[Normal (reference), Pre-hypertension, New hypertension, and 
Prior hypertension] and bone mineral density [Normal (refer-
ence), Osteopenia, and Osteoporosis], respectively. The HR of 
all-cause mortality in one group as compared with the refer-
ence group was calculated using multivariable-adjusted Cox 
proportional hazards model. When one of these factors was 
categorized and analyzed, the other four factors were adjusted, 
as well as gender, cigarette smoking, alcohol drinking, and 
dyslipidemia. Stratified analyses according to sex were per-
formed in all multivariable-adjusted Cox analyses. Population 
attributable risk percent (PAR%) was calculated following the 
formula: PAR% = Pe (RR − 1)/[1 + Pe (RR − 1)] [18], where 
 Pe represented the proportion of exposure in the total popu-
lation, and HR was considered as RR in Cox analysis. All 
analyses were performed using SPSS version 19.0. Statistical 
tests were two-sided and a P < 0.05 was considered statistically 
significant.
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Results
Baseline characteristics and major causes of death 
in the study population
As shown in Table 1, the mean age of participants was 
63.7 years (46.0–95.8 years) at baseline, and 42.5% of them 
were men. Compared to women, men were more likely to be 
cigarette smokers or alcohol consumers, to have hyperten-
sion, dyslipidemia or diabetes, but less likely to have osteo-
porosis (all P < 0.001).
During the mean follow-up of 5.4 years (35,739 person-
years in total), we have documented 370 deaths, including 
157 from malignant neoplasms, 70 from heart diseases, 68 
from cerebrovascular diseases, 26 from diabetes, 11 from 
respiratory diseases, 10 from digestive diseases, 8 from acci-
dents, 3 from dementia, and the rest from other causes. The 
age-standardized mortality rate was 798.2 per 100,000 per-
son-years (927.9 per 100,000 person-years among men and 
716.7 per 100,000 person-years among women). Age-stand-
ardized mortality rate and the percentage of total deaths for 
the eight leading causes of death are shown in Table 2. Over-
all, the three leading causes of death (malignant neoplasms, 
heart diseases, and cerebrovascular diseases) accounted for 
79.7% of total deaths (76.2% among men and 84.3% among 
women). The distribution of most cause-specific mortality 
was similar between men and women, except for mortality 
from respiratory diseases and accidents, which were higher 
in men than women. Moreover, the five leading causes of 
death from malignant neoplasms were cancer of the lung, 
colon and rectum, liver, stomach, and prostate in men, and 
cancer of the lung, colon and rectum, stomach, breast, and 
ovary in women (Fig. 1).
Predictors of all‑cause mortality
The multivariable-adjusted HR and PAR% of all-cause 
mortality for major predictive factors are shown in Table 3. 
Aging was the independent predictor of all-cause mortality, 
with an HR of 1.11 (95%CI1.10–1.13) per 1-year increment. 
Diabetes was responsible for 19.7% of the total mortality, 
with an HR of 1.91 (95%CI 1.51–2.42). In participants 
with diabetes, the risk of all-cause mortality was higher 
among women than men (HR 2.34 vs. 1.61). Osteoporosis 
accounted for 11.7% of the total mortality, with an HR of 
1.71 (95%CI 1.24–2.35). Cigarette smoking significantly 
increased the risk of all-cause mortality among men, with an 
HR of 1.44 (95%CI 1.01–2.06) and PAR% of 53.5%. How-
ever, the presence of hypertension, obesity or dyslipidemia 
at baseline was not associated with the increased risk of 
all-cause mortality in our study.
Table 1  Baseline characteristics 
of participants
Data are presented as mean ± standard deviations or as number (percentage)
BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pres-
sure, TC total cholesterol, TG triglyceride, LDL-C low-density lipoprotein cholesterol, HDL-C high-density 
lipoprotein cholesterol, FPG fasting plasma glucose, 2-h PG 2-hour plasma glucose in 75-g oral glucose 
tolerance test
Total (N = 6591) Men (N = 2804) Women (N = 3787) P
Age (years) 63.7 ± 9.7 64.5 ± 9.8 63.0 ± 9,6 < 0.001
BMI (kg/m2) 24.3 ± 3.3 24.5 ± 3.1 24.1 ± 3.5 < 0.001
WC (cm) 84.0 ± 9.7 87.0 ± 9.2 81.9 ± 9.5 < 0.001
SBP (mmHg) 135.8 ± 19.2 137.2 ± 18.3 134.7 ± 20.0 < 0.001
DBP (mmHg) 76.3 ± 10.2 78.4 ± 10.3 74.8 ± 9.8 < 0.001
TC (mmol/L) 5.07 ± 0.94 4.76 ± 0.88 5.29 ± 0.92 < 0.001
TG (mmol/L) 1.71 ± 1.23 1.72 ± 1.26 1.70 ± 1.20 0.601
HDL-C (mmol/L) 1.43 ± 0.38 1.29 ± 0.32 1.53 ± 0.38 < 0.001
LDL-C (mmol/L) 2.89 ± 0.81 2.72 ± 0.76 3.01 ± 0.81 < 0.001
FPG (mmol/L) 5.63 ± 1.55 5.75 ± 1.70 5.54 ± 1.43 < 0.001
2-h PG (mmol/L) 7.63 ± 3.31 7.86 ± 3.45 7.47 ± 3.19 < 0.001
Smokers, n (%) 1496 (22.7) 1415 (50.6) 81 (2.1) < 0.001
Regular alcohol consumers, n (%) 1089 (16.6) 948 (33.9) 141 (3.7) < 0.001
Existing diseases
 Obesity, n (%) 806 (12.4) 327 (11.8) 479 (12.8) 0.241
 Diabetes, n (%) 1448 (22.3) 703 (25.4) 745 (19.9) < 0.001
 Hypertension, n (%) 3636 (55.6) 1674 (60.2) 1962 (52.2) < 0.001
 Dyslipidemia, n (%) 2172 (33.1) 979 (35.1) 1193 (31.6) 0.003
 Osteoporosis, n (%) 576 (9.4) 71 (2.7) 505 (14.3) < 0.001
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Table 2  Age-standardized mortality and the percentage of total deaths for the eight leading causes of death in the middle-aged and elderly Chi-
nese population
a Causes of death were coded according to the International Classification of Diseases, Tenth Revision (ICD-10). Percentages do not necessarily 
sum to 100 because of rounding
b Age-standardized mortality (per 100,000 person-years) was calculated according to the 2010 census data for China’s population
c Heart diseases included acute rheumatic fever, chronic rheumatic heart disease, hypertensive disease, ischemic heart disease, diseases of the 
pulmonary circulation, and other forms of heart disease
d Accidents included vehicular accidents, falls, drowning, and poisoning
Cause of  deatha No. of deaths Mortality (per 100,000 
person-year)
Age-standardized mortality (per 
100,000 person-year)b




 Total 370 1035.3 798.2 100.0 –
 Men 210 1399.0 927.9 100.0 –
 Women 160 773.0 716.7 100.0 –
Malignant neoplasms
 Total 157 439.3 312.1 42.4 1
 Men 87 579.6 370.0 41.4 1
 Women 70 338.2 263.4 43.8 1
Heart  diseasesc
 Total 70 195.9 170.7 18.9 2
 Men 36 239.8 161.6 17.1 3
 Women 34 164.3 190.5 21.3 2
Cerebrovascular diseases
 Total 68 190.3 160.2 18.4 3
 Men 37 246.5 184.5 17.6 2
 Women 31 149.8 154.2 19.4 3
Diabetes mellitus
 Total 26 72.8 51.6 7.0 4
 Men 15 99.9 63.8 7.1 4
 Women 11 53.1 36.5 6.9 4
Respiratory diseases
 Total 11 30.8 22.9 3.0 5
 Men 10 66.6 39.7 4.8 5
 Women 1 4.8 2.6 0.6 8
Digestive diseases
 Total 10 28.0 21.2 2.7 6
 Men 6 40.0 26.6 2.9 6
 Women 4 19.3 15.9 2.5 5
Accidentsd
 Total 8 22.4 13.4 2.2 7
 Men 6 40.0 21.6 2.9 7
 Women 2 9.7 5.1 1.3 6
Dementia
 Total 3 8.4 5.4 0.8 8
 Men 1 6.7 2.8 0.5 8
 Women 2 9.7 8.2 1.3 7
All other causes
 Total 17 47.6 40.7 4.6 –
 Men 12 79.9 57.3 5.7 –
 Women 5 24.2 40.3 3.1 –
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As shown in Table 4, the HR of all-cause mortality in 
participants aged ≥ 75 years was nearly 26.6 times of that in 
participants aged 45–54 years. Participants who were under-
weight had a significantly higher risk of all-cause mortal-
ity than participants with normal weight (HR, 95%CI 1.73, 
1.04–2.88). Osteoporosis independently predicted the risk 
of all-cause mortality among men, but not among women. 
Osteopenia could not predict the risk of all-cause mortality 
either among men or women. However, hypertension still 
had no significant association with all-cause mortality even 
we categorized it into pre-hypertension, newly diagnosed 
hypertension, and prior known hypertension.
Predictors of cardiovascular diseases and malignant 
neoplasms mortality
As shown in Table 5, the risk of cardiovascular mortality 
increased by 13.6% (12.8% among men and 15.0% among 
women) with per 1-year increase in age. Diabetes and oste-
oporosis independently predicted the risk of cardiovascu-
lar mortality among women, with an HR of 3.27 (95%CI 
1.82–5.88) and 1.89 (95%CI 1.04–3.46) respectively, but 
not among men. The risk of malignant neoplasms mortal-
ity increased by 9.9% (9.8% among men and 9.6% among 
women) with per 1-year increase in age. Compared with 
Fig. 1  Age-standardized 
mortality for the five leading 
causes of death from malignant 
neoplasms
Table 3  Hazard ratio and 
population attributable 
risk percent of predictors 
for all-cause mortality in 
multivariable-adjusteda analyses
HR hazard ratio, 95%CI 95% confidence interval, PAR% population attributable risk percent
a Adjusted for age, gender, cigarette smoking, alcohol drinking, and existing diseases (obesity, diabetes, 
hypertension, dyslipidemia, and osteoporosis) at baseline
Total Men Women
HR (95%CI) PAR% HR (95%CI) PAR% HR (95%CI) PAR%
Age (years) 1.11 (1.10–1.13) – 1.11 (1.09–1.13) – 1.11 (1.09–1.13) –
Smoking 1.29 (0.93–1.80) – 1.44 (1.01–2.06) 53.5 0.78 (0.24–2.57) –
Drinking 1.01 (0.72–1.42) – 0.86 (0.59–1.26) – 2.02 (0.96–4.25) –
Obesity 1.18 (0.86–1.63) – 1.27 (0.82–1.99) – 1.10 (0.69–1.73) –
Diabetes 1.91 (1.51–2.42) 19.7 1.61 (1.18–2.20) 29.5 2.34 (1.62–3.37) 12.9
Hypertension 1.06 (0.81–1.40) – 1.05 (0.74–1.51) – 1.09 (0.71–1.68) –
Dyslipidemia 1.08 (0.85–1.37) – 0.97 (0.70–1.36) – 1.23 (0.87–1.75) –
Osteoporosis 1.71 (1.24–2.35) 11.7 2.51 (1.50–4.21) 1.8 1.48 (1.00–2.21) 22.8
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participants with normal glucose regulation, the risk 
of malignant neoplasms mortality increased by 49% in 
patients with diabetes (HR, 95%CI 1.49, 1.03–2.14). Osteo-
porosis independently predicted the risk of malignant neo-
plasms mortality among men, with an HR of 2.39 (95%CI 
1.07–5.33), but not among women.
Discussion
In the present study, we found that malignant neoplasms, 
heart diseases, and cerebrovascular diseases were the three 
leading causes of death and together accounted for approxi-
mately four-fifths of the total mortality. After them, diabe-
tes mellitus was the fourth leading cause of death. Aging, 
smoking, underweight, diabetes, and osteoporosis were the 
independent predictors of death.
Monitoring the levels and trends in mortality is crucial 
to determining how societies can address prominent sources 
for premature death. Our findings provide important implica-
tions for public health. In a recent global study [19], Fore-
man and colleagues developed a new model and used data 
from the GBD 2016 study [1] to forecast life expectancy, all-
cause mortality, and risk factors of death from 2016 to 2040. 
Their results showed that NCDs would account for a higher 
proportion of years of life lost (YLLs) by 2040 (67·3% of 
YLLs [95% UI 61·9–72·3] globally) than 2016. YLLs were 
calculated from the sum of each death multiplied by the 
standard life expectancy at each age. For most countries, 
prioritizing NCDs and NCD-related risks in health plan-
ning and investment decisions has the potential to markedly 
reduce premature mortality by 2040. In our study, NCDs 
(malignant neoplasms, heart diseases, cerebrovascular 
diseases, and diabetes) were the leading causes of death. 
These results were mostly consistent with Foreman’s study. 
Table 4  Adjusteda hazard ratio 
and 95% confidence interval of 
all-cause mortality by various 
characteristics of participants
HR hazard ratio, 95%CI 95% confidence interval, BMI body mass index, DM diabetes mellitus
a Multivariable-adjusted Cox regression analyses, when one of these factors was categorized and analyzed, 
the other four factors were adjusted, as well as gender, cigarette smoking, alcohol drinking, and dyslipi-
demia
Ref. The reference group was the 45–54 years age group, the 18.5 to < 24.0 kg/m2 group, the normal glucose 
metabolism group, the normal blood pressure group, and the normal bone mineral density group, respec-
tively
Total Men Women
HR 95%CI HR 95%CI HR 95%CI
Age (years)
 45–54Ref. 1.00 Ref. 1.00 Ref. 1.00 Ref.
 55–64 3.72 1.68–8.26 3.08 1.06–8.96 4.95 1.38–15.32
 65–74 9.84 4.52–21.43 11.13 4.00–31.01 8.03 2.41–26.76
  ≥ 75 26.57 12.27–57.54 25.61 9.22–71.11 27.00 8.24–88.45
BMI (kg/m2)
 < 18.5 1.73 1.04–2.88 2.04 1.08–3.86 1.46 0.62–3.44
 18.5 to < 24.0Ref. 1.00 Ref. 1.00 Ref. 1.00 Ref.
 24.0 to < 28.0 0.81 0.62–1.05 0.71 0.50–1.01 0.98 0.65–1.48
  ≥ 28.0 1.07 0.76–1.52 1.09 0.68–1.76 1.09 0.65–1.82
Glucose metabolism
 NormalRef. 1.00 Ref. 1.00 Ref. 1.00 Ref.
 Pre-DM 1.11 0.81–1.51 1.11 0.74–1.66 1.11 0.68–1.81
 New DM 1.80 1.30–2.49 1.34 0.86–2.09 2.46 1.51–4.03
 Prior DM 2.17 1.60–2.96 2.02 1.35–3.01 2.42 1.47–3.97
Blood pressure (mmHg)
 NormalRef. 1.00 Ref. 1.00 Ref. 1.00 Ref.
 Pre-hypertension 0.90 0.54–1.48 0.63 0.33–1.20 1.43 0.64–3.21
  New hypertension 0.59 0.34–1.03 0.46 0.23–0.93 0.84 0.34–2.11
  Prior hypertension 1.11 0.70–1.77 0.85 0.47–1.53 1.60 0.75–3.42
Bone mass
 NormalRef. 1.00 Ref. 1.00 Ref. 1.00 Ref.
 Osteopenia 1.25 0.96–1.64 1.22 0.88–1.70 1.18 0.73–1.90
 Osteoporosis 1.98 1.37–2.86 2.72 1.59–4.64 1.69 0.98–2.90
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However, diabetes has become the fourth leading cause of 
death in our population but ranked as the eighth leading 
cause in Foreman’s study. This observation may be due to 
the substantial increases in the prevalence of diabetes dur-
ing the past three decades in China, especially among the 
elderly population. We also found that the distribution of 
most cause-specific mortality was similar between men and 
women, except for respiratory diseases and accidents, this 
may because men are more likely to be cigarette smokers 
and have traffic accidents than women.
The malignant neoplasm was the first leading cause of 
death in our study, the five leading causes of death from 
malignant neoplasms were lung, colon and rectum, liver, 
stomach, and prostate cancer among men, and lung, colon 
and rectum, stomach, breast, and ovarian cancer among 
women. These results were substantially consistent with 
the Chinese cancer mortality report in 2018 [20]. However, 
the ratio of mortality caused by malignant neoplasms in our 
study was higher than that report; this may be because all 
of our participants were older than 45 years [21]. In China, 
lung cancer, female breast cancer, stomach cancer, liver can-
cer, esophageal cancer, as well as colorectal cancer have 
become the major causes of malignant neoplasm mortality 
and resulted in severe burden to our society. Efficient inter-
ventions and control strategies are urgently needed, such as 
changing from calorie-dense diet and sedentary lifestyle to 
fresh fruits and vegetables-rich diet and physically active 
lifestyle, improving national cancer screening programs for 
common cancers, and so on.
Diabetes is a well-recognized risk factor for cardiovascu-
lar and cerebrovascular diseases worldwide [22–24]. Con-
vincing evidence indicates that diabetes is also associated 
with increased risk of several malignant neoplasms [25]. 
Coughlin et al. [26] and Gross et al. [27] found that diabe-
tes was associated with a higher risk of death from colon, 
liver, and pancreatic cancer. However, the causal relation-
ship between diabetes and malignant neoplasms has not 
been established, further researches are needed. Since 1980, 
the prevalence of diabetes has been quadrupled worldwide 
[28]. In China, the prevalence of diabetes has increased from 
0.67% in 1980 to 11.6% in 2010, whereas rates of awareness, 
treatment, and control remain unacceptably low [29–32]. 
Our results showed that diabetes was the leading predictive 
factor of all-cause mortality, cardiovascular mortality, and 
malignant neoplasms mortality, and diabetes was respon-
sible for 19.7% of the all-cause mortality. These results 
were consistent with previous studies which suggested that 
diabetes was closely associated with death from all causes, 
cardiovascular diseases, and malignant neoplasms [33–35]. 
Coughlin et al. [26] and Gross et al. [27] found that diabe-
tes was associated with a higher risk of death from colon, 
liver, and pancreatic cancer. Even so, the causal relation-
ship between diabetes and malignant neoplasms has not been 
established, further researches are needed.
Table 5  Adjusteda hazard ratio 
and 95% confidence interval of 
predictors for cardiovascular 
and malignant neoplasms 
mortality
HR hazard ratio, 95%CI 95% confidence interval
a Adjusted for age, gender, cigarette smoking, alcohol drinking, and existing diseases (obesity, diabetes, 
hypertension, dyslipidemia, and osteoporosis) at baseline
Total Men Women
HR 95%CI HR 95%CI HR 95%CI
Cardiovascular mortality
 Age (years) 1.14 (1.11–1.16) 1.13 (1.09–1.17) 1.15 (1.11–1.20)
 Smoking 1.57 (0.90–2.76) 1.77 (0.96–3.26) – –
 Drinking 0.88 (0.48–1.60) 0.84 (0.44–1.61) 0.81 (0.11–5.90)
 Obesity 0.98 (0.56–1.72) 1.36 (0.65–2.85) 0.65 (0.27–1.57)
 Diabetes 2.03 (1.37–3.00) 1.36 (0.79–2.34) 3.27 (1.82–5.88)
 Hypertension 1.52 (0.91–2.54) 1.86 (0.89–3.88) 1.17 (0.56–2.42)
 Dyslipidemia 1.212 (0.82–1.80) 1.26 (0.73–2.20) 1.10 (0.62–1.95)
 Osteoporosis 1.92 (1.16–3.18) 2.31 (0.90–5.95) 1.89 (1.04–3.46)
Malignant neoplasms mortality
 Age (years) 1.10 (1.08–1.12) 1.10 (1.07–1.13) 1.10 (1.06–1.13)
 Smoking 1.04 (0.63–1.73) 1.15 (0.67–1.99) 1.12 (0.26–4.93)
 Drinking 1.12 (0.67–1.87) 0.90 (0.51–1.59) 2.56 (0.98–6.67)
 Obesity 1.25 (0.78–1.99) 0.81 (0.37–1.80) 1.72 (0.93–3.16)
 Diabetes 1.49 (1.03–2.14) 1.50 (0.93–2.42) 1.39 (0.79–2.45)
 Hypertension 0.83 (0.56–1.22) 0.83 (0.50–1.39) 0.86 (0.47–1.55)
 Dyslipidemia 1.23 (0.87–1.75) 1.10 (0.67–1.81) 1.56 (0.93–2.62)
 Osteoporosis 1.21 (0.72–2.03) 2.39 (1.07–5.33) 0.93 (0.48–1.79)
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Except for traditional risk factors such as aging, ciga-
rette smoking, underweight, and diabetes, we also found that 
osteoporosis was an independent predictor of all-cause and 
malignant neoplasms caused mortality among men, and car-
diovascular mortality among women, this observation was 
not mentioned in the Foreman’s study [19]. The association 
between osteoporosis and death may be mediated by osteo-
porotic fracture, which has become a major cause of death 
in the elderly population [36]. Osteoporosis is common in 
older women because of progressive postmenopausal bone 
loss due to the decreasing of estrogen levels. Although the 
prevalence of osteoporosis in men was significantly lower 
than women whether in our study or other existing data 
[37], men with osteoporosis might have higher mortality 
than women [38]. The causes of osteoporosis in men were 
more complex than that in women, such as androgen depri-
vation therapy for prostate cancer and alcohol excess. These 
may partly explain why osteoporosis can predict the risk of 
malignant neoplasms mortality among men. In line with our 
results, previous studies also found that osteoporosis was 
closely associated with the increased risk of cardiovascular 
diseases and mortality, especially among women [39, 40]. 
Further studies are needed to elucidate the mechanism of 
these associations.
In our study, cigarette smokers had a 44% higher risk of 
all-cause mortality than those who never smoked among 
men, but not among women. This is mainly because of 
the limited statistical power, because much fewer women 
(2.1%) smoked than men (50.6%) in our population. Our 
results were consistent with those from several prospective 
cohort studies and case–control studies conducted in China 
[41–43]. Underweight was also an independent predictor 
of all-cause mortality in our population. The risk of all-
cause mortality increased by 73% in participants who were 
underweight than those with normal weight. Underweight 
reflected malnutrition and was considered as the leading 
cause of the disease burden in China 15 years ago [44], but 
now it is mainly caused by unhealthy diets, malignant neo-
plasms, and other consumptive diseases, all of which can 
increase the risk of death.
However, hypertension, obesity, and dyslipidemia were 
not related with the risk of all-cause mortality in our study 
population; even if we categorized our participants into pre-
hypertension, newly diagnosed hypertension, and previously 
diagnosed hypertension. We think these may be because 
most patients with hypertension or dyslipidemia began to 
take a medication once they were diagnosed, and their blood 
pressure and serum lipid were controlled within the normal 
range in most time. One other explanation might be that 
the follow-up time in our study was not long enough to see 
the impact of hypertension and dyslipidemia on mortality. 
The association between obesity and all-cause mortality is 
still controversial [45, 46]. This may due to the diagnostic 
criterion for obesity is different across studies, and most 
of our obesity participants had a BMI of 28.0 to < 35 kg/
m2, which was considered as mild obesity. Flegal et al. [47] 
reported that mild obesity (BMI 30 to < 35 kg/m2) was not 
associated with higher all-cause mortality, their results were 
consistent with ours.
In the present study, using a large prospective cohort with 
long-term follow-up, we identified the major causes of death 
and its predictors in a representative sample of the middle-
aged and elderly population, providing some guidance for 
government to make health policies. Nevertheless, a few 
limitations need to be noticed in our study. Firstly, we did 
not have autopsy data to confirm the causes of death; this 
may induce some misclassification bias. However, this is 
the most practical way in epidemiology studies. Secondly, 
factors such as education, marital status, social economic 
status, diet quality, and physical activity were not included 
in our analyses partially because of missing values, and this 
will lead to residual confounding. Thirdly, as the death toll 
was relatively small based on the current follow-up time in 
our study, the impact of some risk factors on mortality may 
not be yet apparent, such as hypertension and dyslipidemia.
In conclusion, our study indicated that malignant neo-
plasms, heart diseases, and cerebrovascular diseases were 
three leading causes of death in middle-aged and elderly 
Chinese community population. Moreover, malignant neo-
plasm has become the first leading cause of death instead of 
heart diseases, and diabetes has risen to the fourth cause of 
death. Aging, smoking, underweight, diabetes, and osteopo-
rosis were the independent predictors for premature death, 
and their effect on death might be different between men 
and women. Efficient interventions and control strategies are 
urgently needed, such as changing from calorie-dense diet 
and sedentary lifestyle to diets rich in fresh fruits and veg-
etables as well as a physically active lifestyle, and promoting 
national cancer screening programs for common cancers. 
Beyond that, prevention and control of diabetes and osteo-
porosis, quit smoking, and maintain a healthy weight are 
also very important for reducing the burden of premature 
mortality.
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